HK1258305A1 - Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies - Google Patents

Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies

Info

Publication number
HK1258305A1
HK1258305A1 HK19100671.5A HK19100671A HK1258305A1 HK 1258305 A1 HK1258305 A1 HK 1258305A1 HK 19100671 A HK19100671 A HK 19100671A HK 1258305 A1 HK1258305 A1 HK 1258305A1
Authority
HK
Hong Kong
Prior art keywords
interleukin
antibodies
receptor
formulations containing
containing anti
Prior art date
Application number
HK19100671.5A
Other languages
Chinese (zh)
Inventor
Daniel B Dix
Xiaolin Tang
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of HK1258305A1 publication Critical patent/HK1258305A1/en

Links

HK19100671.5A 2010-10-06 2019-01-15 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies HK1258305A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39028310P 2010-10-06 2010-10-06

Publications (1)

Publication Number Publication Date
HK1258305A1 true HK1258305A1 (en) 2019-11-08

Family

ID=45995014

Family Applications (1)

Application Number Title Priority Date Filing Date
HK19100671.5A HK1258305A1 (en) 2010-10-06 2019-01-15 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies

Country Status (13)

Country Link
AR (1) AR083338A1 (en)
DK (2) DK2624865T3 (en)
ES (2) ES2820246T3 (en)
HK (1) HK1258305A1 (en)
HR (1) HRP20181822T1 (en)
HU (1) HUE052089T2 (en)
LT (1) LT2624865T (en)
PT (1) PT3354280T (en)
RS (1) RS57850B1 (en)
SI (1) SI2624865T1 (en)
TW (7) TWI498121B (en)
UA (1) UA111731C2 (en)
UY (1) UY33652A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3470432T3 (en) 2012-08-21 2022-02-07 Sanofi Biotechnology Methods for treating or preventing asthma by administering an il-4r antagonist
LT3010539T (en) * 2013-06-21 2019-10-10 Sanofi Biotechnology Methods for treating nasal polyposis by administering an il-4r antagonist
RS59354B1 (en) * 2013-06-21 2019-10-31 Sanofi Biotechnology Methods for treating nasal polyposis by administering an il-4r antagonist
US10066017B2 (en) 2014-11-14 2018-09-04 Sanofi Biotechnology Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist
JP7315545B2 (en) 2017-10-30 2023-07-26 サノフィ・バイオテクノロジー Methods for treating or preventing asthma by administering an IL-4R antagonist

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608693B2 (en) * 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
ES2332082B1 (en) * 2008-07-24 2010-10-26 Consejo Superior De Investigaciones Cientificas (Csic) 45% PATTERN ALIGNMENT SYSTEM IN A SUBSTRATE BY LITOGRAPHY BY ESTENCIL.
JP4487083B2 (en) * 2008-09-10 2010-06-23 日本エクスラン工業株式会社 Cross-linked acrylate fiber and method for producing the same
SG174258A1 (en) * 2009-03-06 2011-10-28 Genentech Inc Antibody formulation

Also Published As

Publication number Publication date
AR083338A1 (en) 2013-02-21
DK2624865T3 (en) 2018-10-22
LT2624865T (en) 2018-10-25
TWI718890B (en) 2021-02-11
TW202102262A (en) 2021-01-16
ES2687813T3 (en) 2018-10-29
TW201542229A (en) 2015-11-16
HRP20181822T1 (en) 2018-12-28
TW202026011A (en) 2020-07-16
TWI498121B (en) 2015-09-01
PT3354280T (en) 2020-09-01
TW201716086A (en) 2017-05-16
TW201924718A (en) 2019-07-01
SI2624865T1 (en) 2018-10-30
DK3354280T3 (en) 2020-09-28
TW202320851A (en) 2023-06-01
TWI690329B (en) 2020-04-11
UY33652A (en) 2012-04-30
RS57850B1 (en) 2018-12-31
TWI568445B (en) 2017-02-01
TW201221141A (en) 2012-06-01
UA111731C2 (en) 2016-06-10
TWI782325B (en) 2022-11-01
ES2820246T3 (en) 2021-04-20
HUE052089T2 (en) 2021-04-28
TWI679988B (en) 2019-12-21

Similar Documents

Publication Publication Date Title
IL283424A (en) Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies
HRP20181821T1 (en) Stabilized formulations containing anti-interleukin-6 receptor (il-6r) antibodies
IL265501A (en) Stabilized antibody-containing liquid formulations
HRP20170983T1 (en) High concentration antibody formulations
RS61082B1 (en) Stable antibody containing compositions
HK1258305A1 (en) Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies
EP2588141A4 (en) Antibody formulations